BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35325018)

  • 21. The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination.
    Schipani F; Manerba M; Marotta R; Poppi L; Gennari A; Rinaldi F; Armirotti A; Farabegoli F; Roberti M; Di Stefano G; Rocchia W; Girotto S; Tirelli N; Cavalli A
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of conformational transitions of h-BRCA2 functional domain and unclassified variant Arg2502Cys using multimodal approach.
    Khan MA; Siddiqui MQ; Kuligina E; Varma AK
    Int J Biol Macromol; 2022 Jun; 209(Pt A):716-724. PubMed ID: 35413318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and interaction of BRC4 analogous peptides with RAD51(241-260).
    Li J; Lu K; Lv M; Liu G; Ma L; Qi J
    Amino Acids; 2020 Mar; 52(3):361-369. PubMed ID: 31875260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
    Dines JN; Shirts BH; Slavin TP; Walsh T; King MC; Fowler DM; Pritchard CC
    Genet Med; 2020 May; 22(5):825-830. PubMed ID: 31911673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51.
    Carreira A; Hilario J; Amitani I; Baskin RJ; Shivji MK; Venkitaraman AR; Kowalczykowski SC
    Cell; 2009 Mar; 136(6):1032-43. PubMed ID: 19303847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment.
    Toland AE; Andreassen PR
    J Med Genet; 2017 Nov; 54(11):721-731. PubMed ID: 28866612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor.
    Lee M; Daniels MJ; Garnett MJ; Venkitaraman AR
    Oncogene; 2011 Jul; 30(30):3360-9. PubMed ID: 21399666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma brucei BRCA2 acts in a life cycle-specific genome stability process and dictates BRC repeat number-dependent RAD51 subnuclear dynamics.
    Trenaman A; Hartley C; Prorocic M; Passos-Silva DG; van den Hoek M; Nechyporuk-Zloy V; Machado CR; McCulloch R
    Nucleic Acids Res; 2013 Jan; 41(2):943-60. PubMed ID: 23222131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling.
    Moghadasi S; Hofland N; Wouts JN; Hogervorst FB; Wijnen JT; Vreeswijk MP; van Asperen CJ
    J Med Genet; 2013 Feb; 50(2):74-9. PubMed ID: 23231788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA2 regulates DMC1-mediated recombination through the BRC repeats.
    Martinez JS; von Nicolai C; Kim T; Ehlén Å; Mazin AV; Kowalczykowski SC; Carreira A
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3515-20. PubMed ID: 26976601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction.
    Caleca L; Catucci I; Figlioli G; De Cecco L; Pesaran T; Ward M; Volorio S; Falanga A; Marchetti M; Iascone M; Tondini C; Zambelli A; Azzollini J; Manoukian S; Radice P; Peterlongo P
    Front Oncol; 2018; 8():480. PubMed ID: 30410870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the missense mutations in canine BRCA2 on BRC repeat 3 functions and comparative analyses between canine and human BRC repeat 3.
    Yoshikawa Y; Ochiai K; Morimatsu M; Suzuki Y; Wada S; Taoda T; Iwai S; Chikazawa S; Orino K; Watanabe K
    PLoS One; 2012; 7(10):e45833. PubMed ID: 23071527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valine 1532 of human BRC repeat 4 plays an important role in the interaction between BRCA2 and RAD51.
    Ochiai K; Yoshikawa Y; Yoshimatsu K; Oonuma T; Tomioka Y; Takeda E; Arikawa J; Mominoki K; Omi T; Hashizume K; Morimatsu M
    FEBS Lett; 2011 Jun; 585(12):1771-7. PubMed ID: 21601571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction.
    Subramanyam S; Jones WT; Spies M; Spies MA
    Nucleic Acids Res; 2013 Oct; 41(19):9020-32. PubMed ID: 23935068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
    Borg A; Haile RW; Malone KE; Capanu M; Diep A; Törngren T; Teraoka S; Begg CB; Thomas DC; Concannon P; Mellemkjaer L; Bernstein L; Tellhed L; Xue S; Olson ER; Liang X; Dolle J; Børresen-Dale AL; Bernstein JL
    Hum Mutat; 2010 Mar; 31(3):E1200-40. PubMed ID: 20104584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classification of PTEN missense VUS through exascale simulations.
    Sinha S; Li J; Tam B; Wang SM
    Brief Bioinform; 2023 Sep; 24(6):. PubMed ID: 37843401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of BRCA1 ring finger variants of uncertain significance.
    Sweet K; Senter L; Pilarski R; Wei L; Toland AE
    Breast Cancer Res Treat; 2010 Feb; 119(3):737-43. PubMed ID: 19543972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional assays for analysis of variants of uncertain significance in BRCA2.
    Guidugli L; Carreira A; Caputo SM; Ehlen A; Galli A; Monteiro AN; Neuhausen SL; Hansen TV; Couch FJ; Vreeswijk MP;
    Hum Mutat; 2014 Feb; 35(2):151-64. PubMed ID: 24323938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition.
    Trenner A; Godau J; Sartori AA
    Mol Cancer Ther; 2018 Jul; 17(7):1392-1404. PubMed ID: 29654063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.
    Hart SN; Hoskin T; Shimelis H; Moore RM; Feng B; Thomas A; Lindor NM; Polley EC; Goldgar DE; Iversen E; Monteiro ANA; Suman VJ; Couch FJ
    Genet Med; 2019 Jan; 21(1):71-80. PubMed ID: 29884841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.